---
title: "The 2026 Growth Charade: From Combat Drones to Mediterranean Salads"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291640963.md"
description: "In today's market, everyone is pitching a high-growth narrative. We look at a bizarre grouping of four companies—spanning aerospace, cybersecurity, med-tech, and fast-casual dining—to separate the actual money-makers from the cash-burners."
datetime: "2026-07-03T08:31:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291640963.md)
  - [en](https://longbridge.com/en/news/291640963.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291640963.md)
---

# The 2026 Growth Charade: From Combat Drones to Mediterranean Salads

This is the ultimate joke of the 2026 market and here is why: every company is desperately trying to attach itself to the hottest narrative of the minute. Look at this bizarre lineup shoehorned into a mobility and service theme. We have a cash-burning drone maker, a Mediterranean salad chain, a cybersecurity firm with a new boss, and a med-tech company with basically zero sales. They are all pitching their own revolutionary scripts. Let’s see who is actually executing and who is just blowing smoke.

Let's start with **AIRO Group (AIRO.US)**. In Q1 2026, they pulled in USD 8.9M in total revenue while losing a staggering USD 15.5M. Sure, they just paraded their new RQ-70 drone at the Eurosatory defense show in Paris and boast a backlog of over USD 150M. But the math is ugly. You can't sustain a global defense platform strategy with that kind of burn rate. Good luck with that.

Then we have the anomaly of the group: **CAVA Group (CAVA.US)**. It is the only one actually raking in cash. Q1 2026 net income hit USD 23.6M, and adjusted EBITDA surged 37.6%. They are expanding aggressively, planning to hire over 2,500 people this year, and brilliantly piggybacking on summer travel through a partnership with Airbnb Experiences. Their recent stock outperformance is warranted. They aren't selling pipe dreams; they are selling food.

Moving on to **Rapid7 (RPD.US)**. The cybersecurity firm just swapped its top seat, bringing in Wael Mohamed as the new CEO in June. Analysts are expecting their upcoming quarterly total revenue to dip 2.7% year-over-year, with EPS plummeting nearly 40%. And yet, the stock has recently caught a bid purely on the generic optimism around AI-driven cyber demand. Why aren't you moving faster to fix your shrinking core business instead of letting AI buzzwords do the heavy lifting?

Finally, there is **Pulse Biosciences (PLSE.US)**. Their clinical data from the 2026 Heart Rhythm Society meeting looks flawless, with near-perfect success rates for their ablation system. But here is the brutal truth: Q1 revenue was a paltry USD 400K against a GAAP net loss of USD 18.6M. They elevated Liane Teplitsky to COO in April, clearly desperate to figure out commercialization. With USD 68.3M in cash left, they better figure it out fast.

My view is simple: if you aren't delivering real profits like CAVA, your flashy press releases and glossy tech demos will eventually run out of runway.

_This article does not constitute investment advice._

### Related Stocks

- [PLSE.US](https://longbridge.com/en/quote/PLSE.US.md)
- [AIRO.US](https://longbridge.com/en/quote/AIRO.US.md)
- [CAVA.US](https://longbridge.com/en/quote/CAVA.US.md)
- [RPD.US](https://longbridge.com/en/quote/RPD.US.md)

## Related News & Research

- [DASH Stock Alert: What to Know as FAA Approves DoorDash Delivery Drones](https://longbridge.com/en/news/294248359.md)
- [Pulse Biosciences advances NANOPULSE-AF pivotal study enrollment](https://longbridge.com/en/news/294218345.md)
- [John B. Wood Discloses Investment at Telos Corporation with 9.1% Stake](https://longbridge.com/en/news/293796528.md)
- [Arcos Dorados Holdings Inc. (NYSE:ARCO) Sees Large Drop in Short Interest](https://longbridge.com/en/news/294125292.md)
- [Deep Isolation Selected as Sole Industrial Partner on Three DOE Project GENESIS AI Initiatives](https://longbridge.com/en/news/293933359.md)